The future of combating antimicrobial resistance

Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combating antimicrobial resistance. 

Though AI and whole genome sequencing (WGS) data models are already becoming increasingly accessible in high-income countries, the future of combating AMR depends on including middle to lower-income nations, as well. Further, the community should promote AI tools that are sustainable and future-proof by being regularly updated to respond to current and evolving needs. Finally, the global healthcare community should work to create AI that is inclusive and accounts for the widest-possible potential use cases.